Pilot Trial of KD018 with Neo-Adj Concurrent Chemo-RT in PTs with Rectal CA

Diseases and Conditions Researched

Rectum

What is the purpose of this trial?

To investigate the grade 3-4 toxicity associated with a course of neo-adjuvant chemo-radiation with concomitant Capecitabine and KD018 in patients with T3-T4 and N0-N2, M0 rectal cancer


Participation Guidelines

Age: 18 Years and older

Click here for detailed participation information for this trial.

Sponsor: Yale Cancer Center
Dates:
Last Updated:
Study HIC#: 1404013708